Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure
100%
Atrial Fibrillation
12%
Heart Infarction
11%
Acute Heart Failure
10%
Placebo
9%
Brain Natriuretic Peptide
9%
Biological Marker
8%
Dipeptidyl Carboxypeptidase Inhibitor
8%
Heart Failure with Reduced Ejection Fraction
7%
Beta Adrenergic Receptor Blocking Agent
7%
Coronary Artery Disease
6%
Anemia
6%
Heart Failure with Preserved Ejection Fraction
6%
All Cause Mortality
6%
Erythropoietin
5%
Systolic Heart Failure
5%
Congestive Heart Failure
5%
ST Segment Elevation Myocardial Infarction
5%
Disease
5%
Eplerenone
5%
Medicine and Dentistry
Heart Failure
65%
Atrial Fibrillation
12%
Ejection Fraction
12%
Heart Left Ventricle Ejection Fraction
8%
Cardiovascular System
7%
Acute Decompensated Heart Failure
7%
Heart Failure with Preserved Ejection Fraction
7%
Kidney Function
7%
Biological Marker
6%
Brain Natriuretic Peptide
6%
Coronary Artery Disease
6%
Myocardial Infarction
5%
Hazard Ratio
5%
Disease
5%
Heart Failure with Reduced Ejection Fraction
5%
Keyphrases
Heart Failure
23%
Patients with Heart Failure
16%
Heart Failure with Preserved Ejection Fraction (HFpEF)
11%
Chronic Heart Failure
9%
Heart Failure Patients
8%
Atrial Fibrillation
8%
Acute Heart Failure
7%
Confidence Interval
6%
Hazard Ratio
5%
All-cause Mortality
5%
Heart Failure Hospitalization
5%
Left Ventricular Ejection Fraction
5%
